Successful treatment of resistant Fusarium solani keratitis with liposomal amphotericin B

Journal français d'ophtalmologie
G TouvronG Renard

Abstract

The prognosis for Fusarium keratitis is poor. Effective drugs to treat this infection are therefore needed. A patient presented Fusarium solani keratitis. The infection regressed with topical amphotericin B and intravenous voriconazole. Topical steroids were introduced. There was reactivation and extension of the infection, invading the anterior chamber. Steroids were discontinued and the antifungal treatment was restarted but there was continued deterioration. Recovery was achieved without surgery, with topical voriconazole, topical liposomal amphotericin B, topical natamycin, intravenous liposomal amphotericin B, and intravenous voriconazole. Combined orally and topically administered voriconazole is a promising therapy when the minimum inhibitory concentration is approximately 2 microg/ml. Liposomal amphotericin B seems to be the most effective drug for the different infection stages. Posaconazole is a useful alternative but further investigations must be pursued.

References

Mar 3, 1999·The Journal of Antimicrobial Chemotherapy·E M JohnsonD W Warnock
Aug 25, 2001·The British Journal of Ophthalmology·L XieW Shi
Sep 18, 2002·The British Journal of Ophthalmology·S Verma, S J Tuft
Nov 19, 2002·Antimicrobial Agents and Chemotherapy·David GoldblumStefan Zimmerli
Jun 7, 2003·Cornea·Dilek DursunEduardo C Alfonso
Dec 10, 2003·Journal of Clinical Microbiology·Josep GuarroEnrique Miguez
Dec 18, 2004·Cornea·Anuradha Chowdhary, Kirti Singh
Dec 21, 2004·Acta Ophthalmologica Scandinavica·Anna PolizziSergio C Saccà
Jun 14, 2006·Archives of Ophthalmology·Eduardo C AlfonsoYunhee Lee
Jun 29, 2006·JAMA : the Journal of the American Medical Association·Wei-Boon KhorDonald T H Tan
Aug 24, 2006·JAMA : the Journal of the American Medical Association·Douglas C ChangUNKNOWN Fusarium Keratitis Investigation Team
Dec 26, 2006·American Journal of Ophthalmology·Vatinee Y BunyaElisabeth J Cohen
Jan 24, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·JoAnn A GiaconiEduardo C Alfonso
Jan 30, 2007·American Journal of Ophthalmology·Elmer Y TuDeepak Edward
Jan 30, 2007·American Journal of Ophthalmology·Angélique DonnioHarold Merle
May 6, 2008·Klinische Monatsblätter für Augenheilkunde·C KaufmannM A Thiel
May 21, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Christian K VorwerkW Behrens-Baumann
Sep 25, 2008·Cornea·Thomas GaujouxVincent M Borderie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.